Overview Dividends

(CELH) Celsius Holdings - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US15118V2079

Functional Energy Drinks, Hydration Powders, Ready-To-Drink

Soft Drinks & Non-alcoholic Beverages
Market Cap in USD: 10,525m

IPO / Inception: 2007-02-02
Return 12m vs S&P 500: 38.2%

EPS (Earnings per Share)

EPS CAGR: 4.73%
EPS Trend: 35.4%

Last SUE: 1.01
Qual. Beats: 1

Revenue

Rev. CAGR: 67.73%
Rev. Trend: 89.5%

Last SUE: 0.26
Qual. Beats: 0

Dividends

Currently no dividends paid

Risk via 5d forecast
Volatility	79.4%
Value at Risk 5%th	107%
Relative Tail Risk	-18.29%

Reward TTM
Sharpe Ratio	0.96
Alpha	33.04
CAGR/Max DD	0.08

Character TTM
Hurst Exponent	0.552
Beta	0.901
Beta Downside	0.891

Drawdowns 3y
Max DD	77.86%
Mean DD	35.76%
Median DD	34.44%

Description: CELH Celsius Holdings October 30, 2025

Celsius Holdings, Inc. (NASDAQ: CELH) designs, manufactures, markets and distributes a portfolio of functional energy and hydration beverages-including CELSIUS Originals, Vibe, Essentials, On-the-Go Powder, and Hydration powders-across the United States, North America, Europe, Asia-Pacific and other international markets. Distribution channels span direct-to-store delivery, independent distributors, supermarkets, convenience and drug stores, specialty nutrition retailers, food-service operators, gyms, mass-market chains and e-commerce platforms.

Recent performance highlights include FY 2023 net revenue of approximately $1.8 billion, representing a 45 % year-over-year increase driven largely by strong volume growth in the on-premise (gym and fitness-center) segment and expanding e-commerce sales. The brand’s “zero-sugar, thermogenic” positioning aligns with the broader health-conscious beverage trend, which the Beverage Marketing Corporation estimates will sustain a CAGR of ~5 % through 2027. However, competitive pressure from larger soft-drink conglomerates and the need for continuous innovation in flavor and functional claims remain material risk factors.

For a deeper quantitative view of CELH’s valuation metrics and scenario analysis, you may find the ValueRay platform useful.

Piotroski VR‑10 (Strict, 0-10) 4.0

Net Income (64.4m TTM) > 0 and > 6% of Revenue (6% = 127.6m TTM)

FCFTA 0.10 (>2.0%) and ΔFCFTA -0.01pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 42.93% (prev 78.35%; Δ -35.42pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.11 (>3.0%) and CFO 554.6m > Net Income 64.4m (YES >=105%, WARN >=100%)

Net Debt (55.5m) to EBITDA (129.6m) ratio: 0.43 <= 3.0 (WARN <= 3.5)

Current Ratio 1.89 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (237.2m) change vs 12m ago 1.49% (target <= -2.0% for YES)

Gross Margin 51.38% (prev 49.59%; Δ 1.79pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 61.00% (prev 80.43%; Δ -19.44pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 2.94 (EBITDA TTM 129.6m / Interest Expense TTM 36.3m) >= 6 (WARN >= 3)

Altman Z'' 1.52

(A) 0.17 = (Total Current Assets 1.94b - Total Current Liabilities 1.03b) / Total Assets 5.27b

(B) 0.03 = Retained Earnings (Balance) 165.5m / Total Assets 5.27b

(D) 0.07 = Book Value of Equity 168.1m / Total Liabilities 2.30b

Total Rating: 1.52 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 67.62

1. Piotroski 4.0pt

2. FCF Yield 4.95%

3. FCF Margin 24.63%

4. Debt/Equity 0.29

5. Debt/Ebitda 0.43

6. ROIC - WACC (= -2.87)%

7. RoE 3.41%

8. Rev. Trend 89.47%

9. EPS Trend 35.36%

What is the price of CELH shares?

As of December 22, 2025, the stock is trading at USD 42.80 with a total of 6,720,810 shares traded.
Over the past week, the price has changed by -2.31%, over one month by +9.77%, over three months by -16.63% and over the past year by +60.00%.

Is CELH a buy, sell or hold?

Celsius Holdings has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CELH.

Strong Buy: 8
Buy: 6
Hold: 6
Sell: 1
Strong Sell: 0

What are the forecasts/targets for the CELH price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	63.7	48.8%
Analysts Target Price	63.7	48.8%
ValueRay Target Price	45	5%

CELH Fundamental Data Overview December 19, 2025

Market Cap USD = 10.53b (10.53b USD * 1.0 USD.USD)
P/E Trailing = 371.1818
P/E Forward = 27.8552
P/S = 4.9512
P/B = 9.2456
P/EG = 0.6757
Beta = 1.004
Revenue TTM = 2.13b USD
EBIT TTM = 106.7m USD
EBITDA TTM = 129.6m USD
Long Term Debt = 861.5m USD (from longTermDebt, last quarter)
Short Term Debt = 3.37m USD (from shortTermDebt, last fiscal year)
Debt = 861.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 55.5m USD (from netDebt column, last quarter)
Enterprise Value = 10.58b USD (10.53b + Debt 861.5m - CCE 806.0m)
Interest Coverage Ratio = 2.94 (Ebit TTM 106.7m / Interest Expense TTM 36.3m)
FCF Yield = 4.95% (FCF TTM 523.6m / Enterprise Value 10.58b)
FCF Margin = 24.63% (FCF TTM 523.6m / Revenue TTM 2.13b)
Net Margin = 3.03% (Net Income TTM 64.4m / Revenue TTM 2.13b)
Gross Margin = 51.38% ((Revenue TTM 2.13b - Cost of Revenue TTM 1.03b) / Revenue TTM)
Gross Margin QoQ = 51.34% (prev 51.52%)
Tobins Q-Ratio = 2.01 (Enterprise Value 10.58b / Total Assets 5.27b)
Interest Expense / Debt = 2.12% (Interest Expense 18.2m / Debt 861.5m)
Taxrate = 30.69% (-27.0m / -88.0m)
NOPAT = 74.0m (EBIT 106.7m * (1 - 30.69%))
Current Ratio = 1.89 (Total Current Assets 1.94b / Total Current Liabilities 1.03b)
Debt / Equity = 0.29 (Debt 861.5m / totalStockholderEquity, last quarter 2.96b)
Debt / EBITDA = 0.43 (Net Debt 55.5m / EBITDA 129.6m)
Debt / FCF = 0.11 (Net Debt 55.5m / FCF TTM 523.6m)
Total Stockholder Equity = 1.89b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.22% (Net Income 64.4m / Total Assets 5.27b)
RoE = 3.41% (Net Income TTM 64.4m / Total Stockholder Equity 1.89b)
RoCE = 3.88% (EBIT 106.7m / Capital Employed (Equity 1.89b + L.T.Debt 861.5m))
RoIC = 5.87% (NOPAT 74.0m / Invested Capital 1.26b)
WACC = 8.74% (E(10.53b)/V(11.39b) * Re(9.34%) + D(861.5m)/V(11.39b) * Rd(2.12%) * (1-Tc(0.31)))
Discount Rate = 9.34% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.15%
[DCF Debug] Terminal Value 74.42% ; FCFE base≈382.0m ; Y1≈399.2m ; Y5≈462.6m
Fair Price DCF = 25.07 (DCF Value 6.46b / Shares Outstanding 257.8m; 5y FCF grow 4.81% → 3.0% )
EPS Correlation: 35.36 | EPS CAGR: 4.73% | SUE: 1.01 | # QB: 1
Revenue Correlation: 89.47 | Revenue CAGR: 67.73% | SUE: 0.26 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.28 | Chg30d=-0.002 | Revisions Net=-1 | Analysts=11
EPS next Year (2026-12-31): EPS=1.55 | Chg30d=-0.005 | Revisions Net=+2 | Growth EPS=+21.7% | Growth Revenue=+31.8%

Additional Sources for CELH Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle